Form 4: Pacira BioSciences Executive Sells Shares
Insider Transaction (Form 4)
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, Inc., sold 3,040 shares of common stock on August 17, 2026 for $23.23 per share.
Summary
- Open-market sale: disposed of 3,040 Common Stock at $23.23 ($70,619) on August 17, 2026; holds 216,384 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $70,619 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jonathan Slonin — Officer (Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Open-market sale | Common Stock | 3,040 | $23 | $70.6K | 216,383.646 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Open-market sale (3,040 shares) |
Keywords
insider transaction, Form 4, PCRX, Pacira BioSciences, Inc., bearish, Jonathan Slonin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.